A dose-escalation study of docetaxel, oxaliplatin and S-1 (DOS) as a first-line therapy for patients with unresectable metastatic gastric cancer.

被引：0
|
作者：
Sato, Yasushi
Sagawa, Tamotsu
Takahashi, Yasuo
Ohnuma, Hiroyuki
Hamaguchi, Kyoko
Hirakawa, Masahiro
Fujikawa, Koshi
Okamoto, Koichi
Miyamoto, Hiroshi
Muguruma, Naoki
Takayama, Tetsuji
机构：
[1] Tokushima Univ, Grad Sch Biomed Sci, Tokushima, Japan
[2] Hokkaido Canc Ctr, Sapporo, Hokkaido, Japan
[3] Sapporo Med Univ, Sapporo, Hokkaido, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 04期
关键词：
D O I：
10.1200/JCO.2018.36.4_suppl.174
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
174
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A phase I dose-escalation study of eribulin and S-1 for metastatic breast cancer
    T Sakiyama
    J Tsurutani
    T Iwasa
    H Kawakami
    Y Nonagase
    T Yoshida
    K Tanaka
    Y Fujisaka
    T Kurata
    Y Komoike
    K Nishio
    K Nakagawa
    British Journal of Cancer, 2015, 112 : 819 - 824
  • [32] A phase I dose-escalation study of eribulin and S-1 for metastatic breast cancer
    Sakiyama, T.
    Tsurutani, J.
    Iwasa, T.
    Kawakami, H.
    Nonagase, Y.
    Yoshida, T.
    Tanaka, K.
    Fujisaka, Y.
    Kurata, T.
    Komoike, Y.
    Nishio, K.
    Nakagawa, K.
    BRITISH JOURNAL OF CANCER, 2015, 112 (05) : 819 - 824
  • [33] Combination therapy with docetaxel and S-1 as a first-line treatment in patients with advanced or recurrent gastric cancer: a retrospective analysis
    Kazuaki Tanabe
    Takahisa Suzuki
    Noriaki Tokumoto
    Hideki Yamamoto
    Kazuhiro Yoshida
    Hideki Ohdan
    World Journal of Surgical Oncology, 8
  • [34] Combination therapy with docetaxel and S-1 as a first-line treatment in patients with advanced or recurrent gastric cancer: a retrospective analysis
    Tanabe, Kazuaki
    Suzuki, Takahisa
    Tokumoto, Noriaki
    Yamamoto, Hideki
    Yoshida, Kazuhiro
    Ohdan, Hideki
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2010, 8
  • [35] Docetexal plus S-1 Versus Oxaliplatin plus S-1 for First-Line Treatment of Patients with Advanced Gastric Cancer: A Retrospective Study
    Wang, Mei
    Wu, Meihong
    Wang, Wei
    Wang, Qingshui
    Wang, Yajie
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 (1-2) : 24 - 28
  • [36] A phase Ⅱ trial of oxaliplatin plus S-1 as a first-line chemotherapy for patients with advanced gastric cancer
    YANG Lin
    SONG Yan
    ZHOU Ai-ping
    QIN Qiong
    CHI Yihebali
    HUANG Jing
    WANG Jin-wan
    中华医学杂志（英文版）, 2013, 126 (18) : 3470 - 3474
  • [37] Carboplatin and paclitaxel as first-line treatment of unresectable or metastatic esophageal or gastric cancer.
    Prithviraj, Gopi Kesaria
    Baksh, Kathryn Anissa
    Fulp, William J.
    Meredith, Ken
    Hoffe, Sarah E.
    Shridhar, Ravi
    Almhanna, Khaldoun
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [38] Phase II study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer
    Yasushi Sato
    Tetsuji Takayama
    Tamotsu Sagawa
    Yasuo Takahashi
    Hiroyuki Ohnuma
    Syunichi Okubo
    Naoaki Shintani
    Shingo Tanaka
    Masaya Kida
    Yasuhiro Sato
    Hidetoshi Ohta
    Koji Miyanishi
    Tsutomu Sato
    Rishu Takimoto
    Masayoshi Kobune
    Koji Yamaguchi
    Koichi Hirata
    Yoshiro Niitsu
    Junji Kato
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 721 - 728
  • [39] Phase I study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer
    T Takayama
    Y Sato
    T Sagawa
    T Okamoto
    H Nagashima
    Y Takahashi
    H Ohnuma
    G Kuroiwa
    K Miyanishi
    R Takimoto
    T Matsunaga
    J Kato
    K Yamaguchi
    K Hirata
    Y Niitsu
    British Journal of Cancer, 2007, 97 : 851 - 856
  • [40] Phase II study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer
    Sato, Y.
    Takayama, T.
    Sagawa, T.
    Tanaka, S.
    Takahashi, S.
    Takimoto, R.
    Kato, J.
    Ohnuma, H.
    Takahashi, Y.
    Niitsu, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345